Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
The Danish biotech company confirmed the global study will begin in the second half of 2026
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
Avio Smart Market Stack Limited and Huwel Lifesciences unveil portable, cost-efficient molecular testing platform
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
nSEPIA aims to bring structure to an area long dominated by subjectivity
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
